Peripheral arterial disease and disability from NHANES 2001-2004 data

Journal of Vascular Nursing

Volumn 29, Issue 3, 2011, Pages 104-112

  Widener, Jeanne Malcom ^a  

^a MARSHALL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; DISABLED PERSON; HUMAN; METHODOLOGY; MIDDLE AGED; NUTRITION; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; QUALITY OF LIFE; STATISTICS; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DISABLED PERSONS; HUMANS; MIDDLE AGED; NUTRITION SURVEYS; PERIPHERAL ARTERIAL DISEASE; QUALITY OF LIFE; UNITED STATES;

EID: 80051938893     PISSN: 10620303     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvn.2011.06.002     Document Type: Article

References (24)

1. Hirsch A.T., Murphy T.P., Lovell M.B., et al. Gaps in public knowledge of peripheral arterial disease. The first national PAD public awareness survey. Circulation 2007, 116:2086-2094.
2. Peripheral Arterial Disease Coalition. Stay in Circulation Campaign. PAD Coalition E-News. Accessed July 21, 2011. http://www.padcoalition.org/stay-in-circulation/index.php.
3. National Heart Lung and Blood Institute. NHLBI Launches National Campaign To Educate About Peripheral Arterial Disease - Clogged Arteries in the Legs. , Accessed July 21, 2011. http://www.nih.gov/news/pr/sep2006/nhlbi-13.htm.
4. Johnstone C.C. Living with peripheral vascular disease: a review of the literature. Prof Nurs 2003, 18:446-449.
5. Measuring Healthy Days 2000, United States Centers for Disease Control and Prevention, CDC, Atlanta, GA.
6. Treat-Jacobson D., Walsh M.E. Treating patients with peripheral arterial disease and claudication. J Vasc Nurs 2003, 21:5-14. quiz 5-6.
7. Yao S.T., Hobbs J.T., Irvine W.T. Ankle systolic pressure measurements in arterial disease affecting the lower extremities. Br J Surg 1969, 56:676-679.
8. Aboyans V., Lacroix P., Lebourdon A., et al. The intra- and interobserver variability of ankle-arm blood pressure index according to its mode of calculation. J Clin Epidemiol 2003, 56:215-220.
9. Ware J., Sherbourne C., The M.O.S. 36-item short-form health survey (SF-36): I. conceptual framework and item selection. Med Care 1992, 30:473-483.
10. Kaplan R.M., Bush J.W. Health-related quality of life measurement for evaluation research and policy analysis. Health Psycho 1982, 1:61.
11. Moriarty D., Zack M., Kobau R. The Centers for Disease Control and Prevention's Healthy Days Measures - Population tracking of perceived physical and mental health over time. Health Qual Life Outcomes 2003, 1:37.
12. Verbrugge L.M., Merrill S.S., Liu X. Measuring disability with parsimony. Disabil Rehabil 1999, 21:295-306.
13. Andresen E.M., Catlin T., Wyrwich K. Retest reliability and validity of a surveillance measure of health-related quality of life. Qual Life Res 2001, 10:199.
14. Biochemical verification of tobacco use and cessation. Nicotine Tob Res 2002, 4:149-159. Society for Research on Nicotine and Tobacco.
15. Marso S.P., Hiatt W.R. Peripheral Arterial Disease in Patients With Diabetes. J Am Coll Cardiol 2006, 47:921-929.
16. Chobanian A.V., Bakris G.L., Black H.R., et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1206-1252.
17. Grundy S.M., Hansen B., Smith S.C.J., et al. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 2004, 109:551-556.
18. Rosendorff C., Black H.R., Cannon C.P., et al. (2007). Treatment of hypertension in the prevention and management of ischemic heart disease: A scientific statement from the American heart association council for high blood pressure research and the councils on clinical cardiology and epidemiology and prevention. Circulation 2007, 115:2761-2788.
19. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on the Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel [ATP] III). (NIH Publication No. 02-5215) 2002, National Heart Lung and Blood Institute, National Heart, Lung and Blood Institute, National Institute of Health, US, Bethesda, MD.
20. NHANES Analytic and Reporting Guidelines. Accessed December 20, 2010. http://www.cdc.gov/nchs/nhanes/nhanes_questionnaires.htm.
21. Hosmer D.W., Lemeshow S. Applied logistic regression 2000, Wiley, New York.
22. Hallin A., Bergqvist D., Fugl-Meyer K., et al. Areas of concern, quality of life and life satisfaction in patients with peripheral vascular disease. Eur J Vasc Endovasc Surg 2002, 24:255-263.
23. McDermott M.M., Greenland P., Guralnik J.M., et al. Depressive symptoms and lower extremity functioning in men and women with peripheral arterial disease. J Gen Intern Med 2003, 18:461-467.
24. Olin J.W., Allie D.E., Belkin M., et al. Performance measures. ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance measures for Peripheral arterial disease.). J Vasc Nurs 2011, 29:23-60.